Ra Capital Management as of Sept. 30, 2022
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 81 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A/s Sponsored Adr (ASND) | 16.7 | $782M | 7.6M | 103.26 | |
Biogen Idec (BIIB) | 5.3 | $250M | 938k | 267.00 | |
Cytek Biosciences (CTKB) | 4.2 | $197M | 13M | 14.72 | |
Forma Therapeutics Hldgs SHS | 3.8 | $180M | 9.0M | 19.95 | |
Day One Biopharmaceuticals I (DAWN) | 3.0 | $141M | 7.0M | 20.03 | |
Aerovate Therapeutics (AVTE) | 2.9 | $137M | 8.3M | 16.58 | |
Rhythm Pharmaceuticals (RYTM) | 2.9 | $134M | 5.5M | 24.50 | |
Travere Therapeutics (TVTX) | 2.6 | $121M | 4.9M | 24.64 | |
Bellus Health Com New | 2.6 | $120M | 11M | 10.56 | |
Janux Therapeutics (JANX) | 2.5 | $117M | 8.7M | 13.54 | |
Vaxcyte (PCVX) | 2.3 | $110M | 4.6M | 24.00 | |
Dice Therapeutics | 2.3 | $106M | 5.2M | 20.28 | |
ImmunoGen | 2.2 | $104M | 22M | 4.78 | |
Nkarta (NKTX) | 2.2 | $103M | 7.8M | 13.16 | |
Acumen Pharmaceuticals (ABOS) | 2.1 | $98M | 9.8M | 10.03 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 2.0 | $95M | 2.3M | 40.80 | |
Iteos Therapeutics (ITOS) | 1.8 | $84M | 4.4M | 19.05 | |
Relmada Therapeutics (RLMD) | 1.6 | $74M | 2.0M | 37.02 | |
Pepgen (PEPG) | 1.6 | $74M | 8.1M | 9.08 | |
Geron Corporation (GERN) | 1.5 | $71M | 30M | 2.34 | |
Aclaris Therapeutics (ACRS) | 1.5 | $69M | 4.4M | 15.74 | |
Third Harmonic Bio (THRD) | 1.4 | $66M | 3.5M | 18.97 | |
An2 Therapeutics (ANTX) | 1.4 | $66M | 3.8M | 17.38 | |
Tyra Biosciences (TYRA) | 1.4 | $64M | 7.2M | 8.79 | |
Wave Life Sciences SHS (WVE) | 1.3 | $62M | 17M | 3.61 | |
Verona Pharma Sponsored Ads (VRNA) | 1.3 | $62M | 6.1M | 10.22 | |
Cogent Communications Hldgs Com New (COGT) | 1.3 | $60M | 4.0M | 14.92 | |
Nanostring Technologies (NSTGQ) | 1.3 | $59M | 4.6M | 12.77 | |
Celldex Therapeutics Com New (CLDX) | 1.2 | $58M | 2.1M | 28.11 | |
Gh Research Ordinary Shares (GHRS) | 1.2 | $57M | 4.9M | 11.62 | |
Fulcrum Therapeutics (FULC) | 1.2 | $57M | 7.0M | 8.09 | |
Kinnate Biopharma | 1.1 | $51M | 4.3M | 11.95 | |
Enanta Pharmaceuticals (ENTA) | 1.0 | $47M | 897k | 51.87 | |
Design Therapeutics (DSGN) | 1.0 | $46M | 2.8M | 16.72 | |
89bio (ETNB) | 1.0 | $45M | 7.8M | 5.79 | |
Vor Biopharma (VOR) | 0.9 | $44M | 11M | 3.98 | |
Eliem Therapeutics (ELYM) | 0.9 | $43M | 13M | 3.23 | |
Instil Bio | 0.8 | $37M | 7.7M | 4.84 | |
Rxsight (RXST) | 0.8 | $37M | 3.1M | 12.00 | |
Satsuma Pharmaceuticals Ord | 0.8 | $36M | 5.9M | 6.00 | |
Avidity Biosciences Ord (RNA) | 0.8 | $35M | 2.2M | 16.33 | |
Vera Therapeutics Cl A (VERA) | 0.7 | $34M | 1.6M | 21.31 | |
Rocket Pharmaceuticals (RCKT) | 0.7 | $34M | 2.1M | 15.96 | |
Akero Therapeutics (AKRO) | 0.7 | $33M | 959k | 34.05 | |
Alpine Immune Sciences | 0.7 | $31M | 4.4M | 7.20 | |
Hillevax (HLVX) | 0.6 | $30M | 1.8M | 17.09 | |
Adicet Bio (ACET) | 0.6 | $29M | 2.1M | 14.22 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.6 | $27M | 3.4M | 7.91 | |
Milestone Pharmaceuticals (MIST) | 0.4 | $21M | 2.2M | 9.19 | |
Pmv Pharmaceuticals (PMVP) | 0.4 | $20M | 1.7M | 11.90 | |
Werewolf Therapeutics (HOWL) | 0.4 | $19M | 4.3M | 4.51 | |
Icosavax | 0.4 | $19M | 6.0M | 3.16 | |
Viridian Therapeutics Sponsored Ads (VRDN) | 0.4 | $18M | 880k | 20.51 | |
Relay Therapeutics (RLAY) | 0.3 | $16M | 718k | 22.37 | |
Da32 Life Scnce Class A Com | 0.3 | $15M | 1.5M | 9.73 | |
Bcls Acquisition Corp Com Cl A | 0.3 | $13M | 1.3M | 10.02 | |
Pardes Biosciences | 0.2 | $11M | 6.2M | 1.85 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.2 | $11M | 5.0M | 2.26 | |
Frazier Lifesciences Acqu Cl A Shs | 0.2 | $10M | 1.0M | 9.98 | |
Arya Sciences Acquisitn Corp Class A Ord Shs | 0.2 | $9.8M | 1.0M | 9.80 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.2 | $9.0M | 7.0M | 1.29 | |
Aadi Bioscience (AADI) | 0.2 | $8.3M | 590k | 14.13 | |
5 01 Acquisition Corp Com Cl A | 0.2 | $7.5M | 750k | 10.00 | |
Concert Pharmaceuticals I equity | 0.2 | $7.3M | 1.1M | 6.70 | |
Dbv Technologies S A Sponsored Adr | 0.1 | $6.6M | 3.7M | 1.77 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $6.0M | 610k | 9.90 | |
Solid Biosciences | 0.1 | $5.8M | 12M | 0.47 | |
Athira Pharma (ATHA) | 0.1 | $5.6M | 1.9M | 2.97 | |
Magenta Therapeutics | 0.1 | $5.1M | 3.6M | 1.41 | |
Io Biotech (IOBT) | 0.1 | $5.0M | 1.9M | 2.71 | |
Tenaya Therapeutics (TNYA) | 0.1 | $4.6M | 1.6M | 2.90 | |
Synlogic | 0.1 | $4.4M | 4.6M | 0.95 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $4.4M | 2.6M | 1.69 | |
CVRX (CVRX) | 0.1 | $2.6M | 275k | 9.33 | |
Entera Bio SHS (ENTX) | 0.0 | $2.2M | 2.1M | 1.04 | |
Fusion Pharmaceuticals | 0.0 | $2.0M | 660k | 3.01 | |
Pyxis Oncology Common Stock (PYXS) | 0.0 | $1.5M | 765k | 1.97 | |
Sensei Biotherapeutics (SNSE) | 0.0 | $1.1M | 684k | 1.55 | |
Bolt Biotherapeutics (BOLT) | 0.0 | $789k | 533k | 1.48 | |
Aptinyx | 0.0 | $720k | 2.0M | 0.37 | |
Aeglea Biotherapeutics | 0.0 | $5.0k | 10k | 0.48 |